Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank43
5Y CAGR-40.0%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
-40.0%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 5.31% |
| 2024 | 10.39% |
| 2023 | -8.54% |
| 2022 | -46.98% |
| 2021 | 134.00% |
| 2020 | 68.47% |
| 2019 | -8.97% |
| 2018 | 88.91% |
| 2017 | 31.81% |
| 2016 | 38.57% |